Guide to buying IDEXX Laboratories stock in Canada

IDEXX Laboratories is a diagnostics & research business based in the US. IDEXX Laboratories stocks (IDXX) are listed on the NASDAQ, and all prices are listed in US Dollars.

Its last market close was $725.93, which is a decrease of 3.97% over the previous week. IDEXX Laboratories employs 11,000 staff and has a trailing 12-month revenue of around $4.2 billion.

Keep reading to see up-to-date IDEXX Laboratories stock price and performance data, along with a step-by-step guide for how to buy IDEXX Laboratories stock in Canada.

IDEXX Laboratories (IDXX) stock summary

Company stock name	IDEXX Laboratories Inc
Stock ticker symbol	IDXX
Exchange	NASDAQ
Open	$738.69
High	$739.15
Low	$724.74
Close	$725.93
Adjusted closing	$725.93
Volume The number of stocks traded during the day	505,139
52-week stock price range	$356.14 – $769.98
Where to buy IDEXX Laboratories stock	Buy on CIBC Investor's Edge

The values in this table are accurate as of the market close on December 2, 2025, and all amounts are in USD.

Can I buy IDEXX Laboratories stock in Canada?

Yes, you can buy IDEXX Laboratories stock in Canada. You simply need to open a brokerage account with an online trading platform that supports stocks on the NASDAQ exchange. Platforms like Interactive Brokers will allow you to directly buy IDEXX Laboratories stock from within Canada.

Dive deeper: Detailed guide on how to buy stocks in Canada

Our top picks for where to buy IDEXX Laboratories stock

IDEXX Laboratories stock chart (NASDAQ: IDXX)

This chart tracks IDEXX Laboratories stock price performance over time.

IDEXX Laboratories stock price

IDEXX Laboratories's stock price at the last available market close was $725.93 (as of December 2, 2025). Keep in mind that IDEXX Laboratories's stock price can be impacted on a daily, or even hourly, basis by factors like company performance, the broader economy and investor sentiments.

Is IDEXX Laboratories stock a buy or sell right now?

The technical analysis gauge above shows real-time buy or sell ratings and analysis for IDEXX Laboratories stock based on your selected timeframe. It uses three widely followed indicators—moving averages, oscillators and pivots—but this does not represent investment advice or a guarantee of success. Finder may not concur with these signals and accepts no responsibility for the performance of your stocks.

Can I buy IDEXX Laboratories stock on the TSX?

No, you cannot buy IDEXX Laboratories stock on the TSX because IDEXX Laboratories stock is not listed on the TSX. Instead, IDEXX Laboratories stock is listed on the NASDAQ under the symbol "IDXX."

That said, if you're wondering how to invest in IDEXX Laboratories stock in Canada, you still have the option to do so by opening a trading account with a Canadian brokerage that gives you access to NASDAQ, like Interactive Brokers.

Dive deeper: Our picks for the best stocks to buy right now in Canada

IDEXX Laboratories stock dividends

IDEXX Laboratories is not expected to pay a dividend over the next 12 months. We'll continue to monitor IDEXX Laboratories's stock information and update this guide if that changes.

IDEXX Laboratories stock performance metrics

Here are some common key metrics for IDEXX Laboratories stock that analysts often use to help gauge a stock's value—P/E ratio, PEG ratio and EBITDA.

• IDEXX Laboratories's P/E ratio

  IDEXX Laboratories's current share price divided by its per-share earnings (EPS) over the past 12 months gives a trailing price/earnings (P/E) ratio of roughly 53x. In other words, IDEXX Laboratories shares trade at around 53 times recent earnings.

  That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the stock or simply that they're over-valued.

• IDEXX Laboratories's PEG ratio

  IDEXX Laboratories's price/earnings-to-growth (PEG) ratio is calculated by dividing its P/E ratio by its earnings growth, which comes out to about 4.4493. A lower ratio can suggest a stock offers better value, while a higher ratio may suggest worse value.

  The PEG ratio provides a broader view than the P/E ratio alone, as it factors in IDEXX Laboratories's expected earnings growth. By accounting for growth, investors can use the PEG ratio to compare the valuations of multiple high-growth companies.

• IDEXX Laboratories's EBITDA

  IDEXX Laboratories's EBITDA (earnings before interest, taxes, depreciation and amortization) is $1.4 billion. EBITDA is a measure of a company's overall financial performance and is often used as a proxy for a company's profitability.

Has IDEXX Laboratories stock ever split?

IDEXX Laboratories's stocks were split on a 2:1 basis on June 15, 2015. So, if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your IDEXX Laboratories stocks, just the quantity.

However, indirectly, the new 50% lower stock price could have impacted the market appetite for IDEXX Laboratories stocks, which in turn could have impacted IDEXX Laboratories's stock price.

How volatile is IDEXX Laboratories stock?

Over the last 12 months, IDEXX Laboratories's stocks price has ranged from $356.14 to as high as $769.98. IDEXX Laboratories's beta measurement of stock volatility is 1.69. For comparison, the market () average beta is 1. This would suggest that IDEXX Laboratories's stocks are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Some analysists use "beta" to gauge a stock's volatility. Beta is a popular way to measure a stocks volatility in relation to the market. Here is a breakdown of IDEXX Laboratories's beta stock volatility rating.

IDEXX Laboratories Inc company and revenue performance

Market Capitalization The total market value of IDEXX Laboratories's outstanding shares	$60.2 billion
Gross profit (TTM)	$2.6 billion
Operating margin (TTM)	32.11%
Profit margin	24.65%
Revenue (TTM)	$4.2 billion
Return on assets (TTM)	24.07%
Return on equity (TTM)	64.63%
Earnings per share (TTM)	$12.58
50-day moving stock price average The average share price over the last 50 days	$664.95
200-day moving stock price average The average share price over the last 200 days	$552.56

All dollar amounts in this table are in USD. TTM refers to the "trailing 12 months." All values are accurate as of the market close on December 2, 2025.

IDEXX Laboratories company profile

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy.

It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays test kits. The company also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E.

coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, it offers diagnostic tests, services, and related instrumentation for manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station.

The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers.

• Common company-related questions about IDEXX Laboratories

  What percentage of IDEXX Laboratories is owned by insiders or institutions?
  Currently 0.684% of IDEXX Laboratories stocks are held by insiders and 95.379% by institutions.

  How many people work for IDEXX Laboratories?
  Latest data suggests 11,000 work at IDEXX Laboratories.

  When does the fiscal year end for IDEXX Laboratories?
  IDEXX Laboratories's fiscal year ends in December.

  Where is IDEXX Laboratories based?
  IDEXX Laboratories's address is: One IDEXX Drive, Westbrook, ME, United States, 04092

  What is IDEXX Laboratories's ISIN number?
  IDEXX Laboratories's international securities identification number is: US45168D1046

  What is IDEXX Laboratories's CUSIP number?
  IDEXX Laboratories's Committee on Uniform Securities Identification Procedures number is: 45168D104

Compare trading platforms to buy IDEXX Laboratories stock

Compare special offers, low fees and a wide range of investment options among popular trading platforms in Canada. Note that the dollar amounts in the table below are in CAD.

Related: Compare the best stock trading platforms in Canada

Do I have to pay tax on gains from IDEXX Laboratories stock sales in Canada?

Yes, you'll need to pay taxes in Canada on investment income, which includes any profit from selling IDEXX Laboratories stock. The CRA taxes investment income from stocks in Canada based on three main factors:

1. Investment income. Investment income includes money earned from interest, dividends or capital gains, which may affect how much you have to pay in taxes on stock sales in Canada.
2. Investor type. Your investment income will be taxed differently depending on whether you're a regular investor or a day trader (which means you buy and trade stocks on a daily basis as your primary form of income).
3. Tax bracket. The higher your tax bracket, the more you'll pay on income from stock sales. Your tax bracket depends on your gross income (minus deductions).

You can learn more about the tax implications of selling stocks in Canada here.

Frequently asked questions about IDEXX Laboratories stock

• Can I buy IDEXX Laboratories stock directly as a Canadian investor?

  Yes, Canadian investors can buy IDEXX Laboratories stock directly through various online brokerage platforms available in Canada. You can compare trading platform options and fees for buying IDEXX Laboratories stock in our table here.

• How much is IDEXX Laboratories stock worth?

  As of the last market close (on December 2, 2025), IDEXX Laboratories stock is worth $725.93 per share.

• Can Canadians buy American stocks?

  Yes, Canadians can buy American stocks through Canadian trading platforms that give access to American stock exchanges such as the NYSE and Nasdaq. The good news is that most Canadian brokerage platforms, like Questrade, Interactive Brokers, Moomoo and Wealthsimple, give access to US exchanges. Read our full guide on how to buy US stocks in Canada to learn more.

• Can I buy fractional shares of IDEXX Laboratories stock?

  Yes, it may be possible to buy fractional shares of IDEXX Laboratories stock depending on the trading platform you're signed up with. Fractional shares can allow you to invest in IDEXX Laboratories stock even when you can't afford its full share price. You can read our full guide to how fractional shares work to learn more.

  The table below shows trading apps in Canada that offer fractional shares:

  3 of 3 results

  Finder Score	Available Asset Types	Account Types	Stock Trading Fee	Monthly Account Fee
  Promoted Finder Score 8.8 Great Interactive Brokers	Finder Score 8.8 Great	Stocks, Bonds, Options, Index Funds, ETFs, Forex, Currencies, Futures	RRSP, TFSA, Personal, Joint	min $1.00, max 0.5%	$0	Go to site More info Compare product selection Compare	loading
  Finder Score 7.4 Great Moomoo Financial Canada	Finder Score 7.4 Great	Stocks, Options, ETFs	RRSP, TFSA, Personal, FHSA	$1.49/stock	$0	Get up to $4,600 in trading perks. T&Cs apply.	Go to site More info Compare product selection Compare	loading
  Finder Score 9.1 Excellent Questrade	Finder Score 9.1 Excellent	Stocks, Bonds, Options, Mutual Funds, Index Funds, ETFs, Forex, GICs, Precious Metals, IPOs	RRSP, RESP, RRIF, TFSA, Personal, Joint, FHSA	$0	$0	Get free contracts, no commissions and a 30 day free trial of Questrade Plus. Use offer code FREEOPTIONS. T&Cs apply.	Go to site More info Compare product selection Compare	loading

  loading

  Load More

  Showing 3 of 3 results

  Finder Score for stock trading platforms

  To make comparing even easier we came up with the Finder Score. Trading costs, account fees and features across 10+ stock trading platforms and apps are all weighted and scaled to produce a score out of 10. The higher the score, the better the platform—it's that simple.

  Read the full methodology

Related: New to stock trading? Compare brokers and get tips for investing.

Important information: Powered by Finder.com. This information is general in nature and is no substitute for professional advice. It does not take into account your personal situation. This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for most investors. You do not own or have any interest in the underlying asset. Capital is at risk, including the risk of losing more than the amount originally put in, market volatility and liquidity risks. Past performance is no guarantee of future results. Tax on profits may apply. Consider the Product Disclosure Statement and Target Market Determination for the product on the provider's website. Consider your own circumstances, including whether you can afford to take the high risk of losing your money and possess the relevant experience and knowledge. We recommend that you obtain independent advice from a suitably licensed financial advisor before making any trades.